Fact CheckerSign in

NCT05744869Not yet recruiting

SBAT for Health Equity

School-based Asthma Therapy to Advance Health Equity Among Historically Marginalized Children

Source: ClinicalTrials.gov · Last updated 13 Oct 2026

Brief summary (registry, in English)

The goal of this research trial is to: 1) Solidify a population health SBAT implementation strategy with our longstanding community collaborators, 2) Perform a district-wide hybrid type 3, stepped-wedge, cluster randomized trial, and 3) Assess the supportive resource utilization and essential features of SBAT to extend sustainability and fidelity in a cost-effective manner.

Status (registry)
Not yet recruiting
Study type
Interventional
Enrollment
300 (estimated)
First submitted
23 Jan 2023
Start date
1 Jul 2027
Primary completion date
31 Jul 2032
Lead sponsor
University of Rochester
Diseases
Asthma
NCT number
NCT05744869

What you commit to

  • Study type: Interventional
  • Planned participants: 300
  • From 1 Jul 2027 to the primary completion date, 31 Jul 2032
  • No sites listed in no country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • In foster care or other situations in which consent cannot be obtained from a guardian.
    • Based on our prior studies, fewer than 10% of subjects are expected to be excluded based on these criteria.

Other illness

  • Having other significant medical conditions, including congenital heart disease, cystic fibrosis, or other chronic lung disease, that could interfere with the assessment of asthma-related measures.

Other

  • Caregiver inability to speak and understand English or Spanish. (\*Participants unable to read will be eligible, and all instruments will be given verbally.)

Who the study is looking for

  • Physician-diagnosed asthma, with persistent symptoms or poor control based on NHLBI criteria
  • Age \>4 and \<12 years
  • Attending school in Rochester City School District
  • Caregiver \>18 years, and is able to understand and speak English or Spanish

Age in the registry: 4 years to 12 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

This page is information, not medical advice. Discuss any trial with your doctor.